RLMD Relmada Therapeutics Inc

USD 3.53 -0.30 -7.832898
Icon

Relmada Therapeutics Inc (RLMD) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 3.53

-0.30 (-7.83)%

USD 0.12B

0.24M

USD -1.00

USD 6.00 (+69.97%)

Icon

RLMD

Relmada Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 3.53
0.00 0
Take a Tour

Relmada Therapeutics Inc (RLMD) Stock Forecast

N/A

Based on the Relmada Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Relmada Therapeutics Inc is not available over the next 12 months. Relmada Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Relmada Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Relmada Therapeutics Inc’s stock price was USD 3.53. Relmada Therapeutics Inc’s stock price has changed by -8.79% over the past week, -24.09% over the past month and +40.08% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...